Icecure Medical Stock Performance

ICCM Stock  USD 0.59  0.02  2.67%   
The company retains a Market Volatility (i.e., Beta) of 1.69, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Icecure Medical will likely underperform. At this point, Icecure Medical has a negative expected return of -0.13%. Please make sure to check out Icecure Medical's total risk alpha and the relationship between the potential upside and market facilitation index , to decide if Icecure Medical performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Icecure Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Last Split Factor
1011:992
Last Split Date
2025-07-09
1
IceCure Medical Releases Earnings Results, Meets Estimates
11/19/2025
2
IceCure Medical Ltd Q3 2025 Earnings Call Transcript
11/20/2025
3
Why IceCure Medical Ltd stock remains on buy lists - July 2025 Movers Real-Time Volume Analysis Alerts - Newser
12/04/2025
4
IceCures ProSense Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting
12/10/2025
5
IceCure Medical Ltd. Short Interest Down 24.0 percent in December
12/31/2025
6
IceCure CEO Issues Letter to Shareholders Reports Record Fourth Quarter and Full Year 2025 ProSense Sales
01/12/2026
7
IceCure Celebrates American Society of Breast Surgeons Proposed Breast Cancer Treatment Guidelines Which Include Cryoablation for Low-Risk Breast Cancer
01/28/2026
8
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense
02/11/2026
Begin Period Cash Flow10.5 M
Total Cashflows From Investing Activities446 K

Icecure Medical Relative Risk vs. Return Landscape

If you would invest  65.00  in Icecure Medical on November 20, 2025 and sell it today you would lose (6.48) from holding Icecure Medical or give up 9.97% of portfolio value over 90 days. Icecure Medical is currently does not generate positive expected returns and assumes 3.1221% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Icecure, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Icecure Medical is expected to under-perform the market. In addition to that, the company is 4.12 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.18 per unit of volatility.

Icecure Medical Target Price Odds to finish over Current Price

The tendency of Icecure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.59 90 days 0.59 
under 95
Based on a normal probability distribution, the odds of Icecure Medical to move above the current price in 90 days from now is under 95 (This Icecure Medical probability density function shows the probability of Icecure Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.69 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Icecure Medical will likely underperform. Additionally Icecure Medical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Icecure Medical Price Density   
       Price  

Predictive Modules for Icecure Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Icecure Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Icecure Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.573.70
Details
Intrinsic
Valuation
LowRealHigh
0.061.194.32
Details
3 Analysts
Consensus
LowTargetHigh
2.843.123.47
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.01-0.01-0.01
Details

Icecure Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Icecure Medical is not an exception. The market had few large corrections towards the Icecure Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Icecure Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Icecure Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.32
β
Beta against Dow Jones1.69
σ
Overall volatility
0.04
Ir
Information ratio -0.09

Icecure Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Icecure Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Icecure Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Icecure Medical generated a negative expected return over the last 90 days
Icecure Medical has some characteristics of a very speculative penny stock
Icecure Medical has high historical volatility and very poor performance
The company reported the previous year's revenue of 3.29 M. Net Loss for the year was (15.32 M) with profit before overhead, payroll, taxes, and interest of 1.04 M.
Icecure Medical currently holds about 17.73 M in cash with (12.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Icecure Medical has a frail financial position based on the latest SEC disclosures
Roughly 40.0% of the company shares are held by company insiders
Latest headline from prnewswire.com: IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense

Icecure Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Icecure Stock often depends not only on the future outlook of the current and potential Icecure Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Icecure Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding50.9 M
Cash And Short Term Investments7.6 M

Icecure Medical Fundamentals Growth

Icecure Stock prices reflect investors' perceptions of the future prospects and financial health of Icecure Medical, and Icecure Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Icecure Stock performance.

About Icecure Medical Performance

By examining Icecure Medical's fundamental ratios, stakeholders can obtain critical insights into Icecure Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Icecure Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 354.92  264.91 
Return On Tangible Assets(1.10)(1.15)
Return On Capital Employed(2.00)(2.10)
Return On Assets(1.10)(1.15)
Return On Equity(2.55)(2.42)

Things to note about Icecure Medical performance evaluation

Checking the ongoing alerts about Icecure Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Icecure Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Icecure Medical generated a negative expected return over the last 90 days
Icecure Medical has some characteristics of a very speculative penny stock
Icecure Medical has high historical volatility and very poor performance
The company reported the previous year's revenue of 3.29 M. Net Loss for the year was (15.32 M) with profit before overhead, payroll, taxes, and interest of 1.04 M.
Icecure Medical currently holds about 17.73 M in cash with (12.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Icecure Medical has a frail financial position based on the latest SEC disclosures
Roughly 40.0% of the company shares are held by company insiders
Latest headline from prnewswire.com: IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense
Evaluating Icecure Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Icecure Medical's stock performance include:
  • Analyzing Icecure Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Icecure Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Icecure Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Icecure Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Icecure Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Icecure Medical's stock. These opinions can provide insight into Icecure Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Icecure Medical's stock performance is not an exact science, and many factors can impact Icecure Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Will Health Care Equipment & Supplies sector continue expanding? Could Icecure diversify its offerings? Factors like these will boost the valuation of Icecure Medical. Market participants price Icecure higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Icecure Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.25)
Revenue Per Share
0.05
Quarterly Revenue Growth
0.284
Return On Assets
(0.63)
Return On Equity
(1.58)
Understanding Icecure Medical requires distinguishing between market price and book value, where the latter reflects Icecure's accounting equity. The concept of intrinsic value - what Icecure Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Icecure Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Icecure Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.